These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1782730

  • 1. Quantitation of beta-thalassemia genes in Quebec immigrants of Mediterranean, southeast Asian, and Asian Indian origins.
    Kaplan F, Kokotsis G, Capua A, Scriver CR.
    Clin Invest Med; 1991 Aug; 14(4):325-30. PubMed ID: 1782730
    [Abstract] [Full Text] [Related]

  • 2. Regional heterogeneity of beta-thalassemia mutations in the multi ethnic Indian population.
    Colah R, Gorakshakar A, Nadkarni A, Phanasgaonkar S, Surve R, Sawant P, Mohanty D, Ghosh K.
    Blood Cells Mol Dis; 2009 Aug; 42(3):241-6. PubMed ID: 19254853
    [Abstract] [Full Text] [Related]

  • 3. Beta-, delta beta-thalassemia and Hb lepore among Yugoslav, Bulgarian, Turkish and Albanian.
    Efremov GD.
    Haematologica; 1990 Aug; 75 Suppl 5():31-41. PubMed ID: 2086380
    [Abstract] [Full Text] [Related]

  • 4. High incidence of the CD8/9 (+G) beta 0-thalassemia mutation in Spain.
    Villegas A, Ropero P, Ataulfo González F, Martí E, Anguita E, de Blas JM.
    Haematologica; 1998 Dec; 83(12):1066-8. PubMed ID: 9949622
    [Abstract] [Full Text] [Related]

  • 5. Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem.
    Boudrahem-Addour N, Zidani N, Carion N, Labie D, Belhani M, Beldjord C.
    Hemoglobin; 2009 Dec; 33(1):24-36. PubMed ID: 19205970
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of beta-thalassemia mutations in Guadeloupe.
    Romana M, Keclard L, Guillemin G, Lavocat E, Saint-Martin C, Berchel C, Mérault G.
    Am J Hematol; 1996 Dec; 53(4):228-33. PubMed ID: 8948659
    [Abstract] [Full Text] [Related]

  • 7. Genetic heterogeneity of Beta thalassemia in Lebanon reflects historic and recent population migration.
    Makhoul NJ, Wells RS, Kaspar H, Shbaklo H, Taher A, Chakar N, Zalloua PA.
    Ann Hum Genet; 2005 Jan; 69(Pt 1):55-66. PubMed ID: 15638828
    [Abstract] [Full Text] [Related]

  • 8. Identification of deletion and triple alpha-globin gene haplotypes in the Montreal beta-thalassemia screening program: implications for genetic medicine.
    Akerman BR, Fujiwara TM, Lancaster GA, Morgan K, Scriver CR.
    Am J Med Genet; 1990 May; 36(1):76-84. PubMed ID: 2333910
    [Abstract] [Full Text] [Related]

  • 9. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran.
    Kiani AA, Mortazavi Y, Zeinali S, Shirkhani Y.
    Hemoglobin; 2007 May; 31(3):343-9. PubMed ID: 17654071
    [Abstract] [Full Text] [Related]

  • 10. [Thalassemic alleles in Mexican mestizos].
    Ibarra B, Perea FJ, Villalobos-Arámbula AR.
    Rev Invest Clin; 1995 May; 47(2):127-31. PubMed ID: 7610281
    [Abstract] [Full Text] [Related]

  • 11. Changes in the epidemiology of thalassemia in North America: a new minority disease.
    Vichinsky EP, MacKlin EA, Waye JS, Lorey F, Olivieri NF.
    Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
    [Abstract] [Full Text] [Related]

  • 12. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
    Darwish HM, El-Khatib FF, Ayesh S.
    Hemoglobin; 2005 Dec; 29(2):119-32. PubMed ID: 15921164
    [Abstract] [Full Text] [Related]

  • 13. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G, Das R, Awasthi A, Ahluwalia J, Marwaha RK.
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [Abstract] [Full Text] [Related]

  • 14. Molecular characterization of beta-thalassemia major and beta-thalassemia intermedia in China and Southeast Asia.
    Kazazian HH, Dowling CE, Waber PG, Huang SZ, Lo WH, Li A, Tam JW, Kang J, Antonarakis SE.
    Prog Clin Biol Res; 1987 Nov; 251():401-12. PubMed ID: 3432272
    [Abstract] [Full Text] [Related]

  • 15. [Most frequent beta-thalassemia mutations in the Argentinian population].
    Varela V, Abreu S, Rossetti LC, Targovnik H.
    Sangre (Barc); 1996 Apr; 41(2):137-40. PubMed ID: 9045354
    [Abstract] [Full Text] [Related]

  • 16. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
    Basak AN.
    Hemoglobin; 2007 Apr; 31(2):233-41. PubMed ID: 17486506
    [Abstract] [Full Text] [Related]

  • 17. Identification of the Chinese IVS-II-654 (C-->T) beta-thalassemia mutation in an immigrant Turkish family: recurrence or migration?
    Tadmouri GO, Bilenoğlu O, Kutlar F, Markowitz RB, Kutlar A, Başak AN.
    Hum Biol; 1999 Apr; 71(2):295-302. PubMed ID: 10222649
    [Abstract] [Full Text] [Related]

  • 18. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R, Nadkarni A, Gorakshakar A, Phanasgaonkar S, Surve R, Subramaniam PG, Bondge N, Pujari K, Ghosh K, Mohanty D.
    Blood Cells Mol Dis; 2004 Apr; 33(2):153-7. PubMed ID: 15315795
    [Abstract] [Full Text] [Related]

  • 19. A pilot beta-thalassaemia screening program in the Albanian population for a health planning program.
    Baghernajad-Salehi L, D'Apice MR, Babameto-Laku A, Biancolella M, Mitre A, Russo S, Di Daniele N, Sangiuolo F, Mokini V, Novelli G.
    Acta Haematol; 2009 Apr; 121(4):234-8. PubMed ID: 19556751
    [Abstract] [Full Text] [Related]

  • 20. [Molecular-genetic characteristics of alpha, beta and delta beta-thalassemias in 139 heterozygotes in 56 unrelated Czech and Slovak families (Priority description of 3 beta-thalassemia mutations, an extensive alpha-thalassemia 2 (18+ kb) deletion and a Swiss-type nondeletion hereditary persistence of hemoglobin F)].
    Indrák K, Divoký V, Brabec V, Indráková J, Svobodová M, Huisman TH.
    Vnitr Lek; 1993 Oct; 39(10):969-78. PubMed ID: 7694425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.